Skip to main content
. 2017 Nov 29;7:16547. doi: 10.1038/s41598-017-16702-w

Figure 3.

Figure 3

Intrathecal IL-27, and IL-35 gene therapy protects EAE mice from tissue damage. Neuropathological analysis of demyelination (A), axonal loss (B), infiltrates (C), and CD3+ T cells (D). The protective effect of IL-27HA gene therapy is associated to a significant decrease of demyelination (E), axonal damage (F), inflammatory infiltrates (G), and number of infiltrating CD3+ T cells (H) (mean ± sd). IL-35HA gene therapy promoted a significant decrease of inflammatory infiltrates (G). *p < 0.05; (1 way anova; E–H n = 5/group). We show here one representative out of three independent experiments.